These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 1774953
1. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Lefebvre P, Thomas G, Gourmel B, Agadir A, Castaigne S, Dreux C, Degos L, Chomienne C. Leukemia; 1991 Dec; 5(12):1054-8. PubMed ID: 1774953 [Abstract] [Full Text] [Related]
2. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Muindi JR, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrell RP. Cancer Res; 1992 Apr 15; 52(8):2138-42. PubMed ID: 1559217 [Abstract] [Full Text] [Related]
3. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Achkar CC, Bentel JM, Boylan JF, Scher HI, Gudas LJ, Miller WH. Drug Metab Dispos; 1994 Apr 15; 22(3):451-8. PubMed ID: 8070324 [Abstract] [Full Text] [Related]
4. [Biological parameters of the efficiency of retinoic acid in acute leukemia]. Chomienne C, Cornic M, Castaigne S, Lefebvre P, de Thé H, Dejean A, Degos L. C R Seances Soc Biol Fil; 1991 Apr 15; 185(6):456-63. PubMed ID: 1822394 [Abstract] [Full Text] [Related]
5. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells. Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS, Gallagher RE. Cancer Res; 1998 Dec 15; 58(24):5770-6. PubMed ID: 9865735 [Abstract] [Full Text] [Related]
10. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP. J Natl Cancer Inst; 1993 Dec 01; 85(23):1921-6. PubMed ID: 8230282 [Abstract] [Full Text] [Related]
11. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]. Hirota T, Fujimoto T, Konno K, Sakakibara Y, Katano N, Tsurusawa M, Takitani K, Miyake M. Rinsho Ketsueki; 1997 Nov 01; 38(11):1170-6. PubMed ID: 9423333 [Abstract] [Full Text] [Related]
12. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin. Kraft JC, Slikker W, Bailey JR, Roberts LG, Fischer B, Wittfoht W, Nau H. Drug Metab Dispos; 1991 Nov 01; 19(2):317-24. PubMed ID: 1676630 [Abstract] [Full Text] [Related]
15. Clinical pharmacology of all-trans retinoic acid. Muindi JR, Young CW, Warrell RP. Leukemia; 1994 Nov 01; 8(11):1807-12. PubMed ID: 7967726 [Abstract] [Full Text] [Related]
16. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N. Srp Arh Celok Lek; 1995 Nov 01; 123(11-12):279-85. PubMed ID: 16296239 [Abstract] [Full Text] [Related]